Yan Mei Goh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yan Mei Goh has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
Achal Khanna
Department of General Surgery, Milton Keynes University Hospital, Milton Keynes, UK
2 shared publications- George Bushra Hanna
Division of Surgery, Department of Surgery and Cancer, Imperial College London, London, UK
2 shared publications Nicole Ellen James
Imperial College London, London, UK
2 shared publications- Abida Sultana
Department of Urology, Russell’s Hall Hospital, DGFT, Dudley, UK
1 shared publication - Ahmed Saad
Department of Trauma and Orthopaedics, Royal Orthopaedic Hospital, Birmingham, UK
1 shared publication C. Gillespie
Department of General and Upper Gastro-Intestinal Surgery, The Royal Infirmary Of Edinburgh, 51 Little France Crescent, Edinburgh, EH16 4SA, United Kingdom
1 shared publication
Latest Publications
- Open Access
- 5 March 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-12
Endogenous aldehyde accumulation generates genotoxicity and exhaled biomarkers in esophageal adenocarcinoma
Volatile aldehydes are enriched in esophageal adenocarcinoma (EAC) patients’ breath and could improve early diagnosis, however the mechanisms of their production are unknown. Here, we show that weak aldehyde detoxification characterizes EAC, which is sufficient to cause endogenous aldehyde accumulation in vitro. Two aldehyde groups are significantly enriched in EAC biopsies and adjacent tissue: (i) short-chain alkanals, and (ii) medium-chain alkanals, including decanal. The short-chain alkanals form DNA-adducts, which demonstrates genotoxicity and confirms inadequate detoxification. Metformin, a putative aldehyde scavenger, reduces this toxicity. Tissue and breath concentrations of the medium-chain alkanal decanal are correlated, and increased decanal is linked to reduced ALDH3A2 expression, TP53 deletion, and adverse clinical features. Thus, we present a model for increased exhaled aldehydes based on endogenous accumulation from reduced detoxification, which also causes therapeutically actionable genotoxicity. These results support EAC early diagnosis trials using exhaled aldehyde analysis.
- 5 March 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-12
Open AccessEndogenous aldehyde accumulation generates genotoxicity and exhaled biomarkers in esophageal adenocarcinoma
Volatile aldehydes are enriched in esophageal adenocarcinoma (EAC) patients’ breath and could improve early diagnosis, however the mechanisms of their production are unknown. Here, we show that weak aldehyde detoxification characterizes EAC, which is sufficient to cause endogenous aldehyde accumulation in vitro. Two aldehyde groups are significantly enriched in EAC biopsies and adjacent tissue: (i) short-chain alkanals, and (ii) medium-chain alkanals, including decanal. The short-chain alkanals form DNA-adducts, which demonstrates genotoxicity and confirms inadequate detoxification. Metformin, a putative aldehyde scavenger, reduces this toxicity. Tissue and breath concentrations of the medium-chain alkanal decanal are correlated, and increased decanal is linked to reduced ALDH3A2 expression, TP53 deletion, and adverse clinical features. Thus, we present a model for increased exhaled aldehydes based on endogenous accumulation from reduced detoxification, which also causes therapeutically actionable genotoxicity. These results support EAC early diagnosis trials using exhaled aldehyde analysis.
- 13 March 2020
- Published by Springer Nature in Surgical Endoscopy
- Vol. 35 (1) , 502
Correction to: The use of endoluminal techniques in the revision of primary bariatric surgery procedures: a systematic review
This article was updated to correct Yan Mei Goh’s name (“Miss” was deleted); it is correct as displayed here.
- 13 March 2020
- Published by Springer Nature in Surgical Endoscopy
- Vol. 35 (1) , 502
Correction to: The use of endoluminal techniques in the revision of primary bariatric surgery procedures: a systematic review
This article was updated to correct Yan Mei Goh’s name (“Miss” was deleted); it is correct as displayed here.
- Open Access
- 28 February 2020
- Published by Springer Nature in Surgical Endoscopy
- Vol. 34 (6) , 2410-2428
The use of endoluminal techniques in the revision of primary bariatric surgery procedures: a systematic review
Background Weight regain following primary bariatric surgery is attributed to anatomical, behavioural and hormonal factors. Dilation of the gastrojejunal anastomosis is a possible cause of weight regain after roux-en-Y gastric bypass (RYGB). However, surgical revision has significant risks with limited benefits. Endoluminal procedures have been suggested to manage weight regain post-surgery. This systematic review aims to assess efficacy of endoluminal procedures. Methods Studies where endoluminal procedures were performed following primary bariatric surgery were identified. Main outcome measures were mean weight loss pre- and post-procedure, excess weight loss, recurrence rates, success rates and post-procedure complications. Results Twenty-six studies were included in this review. Procedures identified were (i) endoluminal plication devices (ii) other techniques e.g. sclerotherapy, mucosal ablation, and Argon Plasma Coagulation (APC) and (iii) combination therapy involving sclerotherapy/mucosal ablation/APC and endoscopic OverStitch device. Endoluminal plication devices show greatest initial weight loss within 12 months post-procedure, but not sustained at 18 months. Only one study utilising sclerotherapy showed greater sustained weight loss with peak EWL (19.9%) at 18 months follow-up. Combination therapy showed the greatest sustained EWL (36.4%) at 18 months. Endoluminal plication devices were more successfully performed in 91.8% of patients and had lower recurrence rates (5.02%) compared to sclerotherapy and APC, with 46.8% success and 21.5% recurrence rates. Both procedures demonstrate no major complications and low rates of moderate complications. Only mild complications were noted for combination therapy. Conclusions The paucity of good quality data limits our ability to demonstrate and support the long-term efficacy of endoluminal techniques in the management of weight regain following primary bariatric surgery. Future work is necessary to not only clarify the role of endoluminal plication devices, but also combination therapy in the management of weight regain following primary bariatric surgery.
- 28 February 2020
- Published by Springer Nature in Surgical Endoscopy
- Vol. 34 (6) , 2410-2428
Open AccessThe use of endoluminal techniques in the revision of primary bariatric surgery procedures: a systematic review
Background Weight regain following primary bariatric surgery is attributed to anatomical, behavioural and hormonal factors. Dilation of the gastrojejunal anastomosis is a possible cause of weight regain after roux-en-Y gastric bypass (RYGB). However, surgical revision has significant risks with limited benefits. Endoluminal procedures have been suggested to manage weight regain post-surgery. This systematic review aims to assess efficacy of endoluminal procedures. Methods Studies where endoluminal procedures were performed following primary bariatric surgery were identified. Main outcome measures were mean weight loss pre- and post-procedure, excess weight loss, recurrence rates, success rates and post-procedure complications. Results Twenty-six studies were included in this review. Procedures identified were (i) endoluminal plication devices (ii) other techniques e.g. sclerotherapy, mucosal ablation, and Argon Plasma Coagulation (APC) and (iii) combination therapy involving sclerotherapy/mucosal ablation/APC and endoscopic OverStitch device. Endoluminal plication devices show greatest initial weight loss within 12 months post-procedure, but not sustained at 18 months. Only one study utilising sclerotherapy showed greater sustained weight loss with peak EWL (19.9%) at 18 months follow-up. Combination therapy showed the greatest sustained EWL (36.4%) at 18 months. Endoluminal plication devices were more successfully performed in 91.8% of patients and had lower recurrence rates (5.02%) compared to sclerotherapy and APC, with 46.8% success and 21.5% recurrence rates. Both procedures demonstrate no major complications and low rates of moderate complications. Only mild complications were noted for combination therapy. Conclusions The paucity of good quality data limits our ability to demonstrate and support the long-term efficacy of endoluminal techniques in the management of weight regain following primary bariatric surgery. Future work is necessary to not only clarify the role of endoluminal plication devices, but also combination therapy in the management of weight regain following primary bariatric surgery.
- Open Access
- 21 February 2020
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2020, 1-13
Metabolic Biomarkers of Squamous Cell Carcinoma of the Aerodigestive Tract: A Systematic Review and Quality Assessment
Introduction. Aerodigestive squamous cell carcinomas (ASCC) constitute a major source of global cancer deaths. Patients typically present with advanced, incurable disease, so new means of detecting early disease are a research priority. Metabolite quantitation is amenable to point-of-care analysis and can be performed in ASCC surrogates such as breath and saliva. The purpose of this systematic review is to summarise progress of ASCC metabolomic studies, with an emphasis on the critical appraisal of methodological quality and reporting. Method. A systematic online literature search was performed to identify studies reporting metabolic biomarkers of ASCC. This review was conducted in accordance with the recommendations of the Cochrane Library and MOOSE guidelines. Results. Thirty studies comprising 2117 patients were included in the review. All publications represented phase-I biomarker discovery studies, and none validated their findings in an independent cohort. There was heterogeneity in study design and methodological and reporting quality. Sensitivities and specificities were higher in oesophageal and head and neck squamous cell carcinomas compared to those in lung squamous cell carcinoma. The metabolic phenotypes of these cancers were similar, as was the kinetics of metabolite groups when comparing blood, tissue, and breath/saliva concentrations. Deregulation of amino acid metabolism was the most frequently reported theme. Conclusion. Metabolite analysis has shown promising diagnostic performance, especially for oesophageal and head and neck ASCC subtypes, which are phenotypically similar. However, shortcomings in study design have led to inconsistencies between studies. To support future studies and ultimately clinical adoption, these limitations are discussed.
- 21 February 2020
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2020, 1-13
Open AccessMetabolic Biomarkers of Squamous Cell Carcinoma of the Aerodigestive Tract: A Systematic Review and Quality Assessment
Introduction. Aerodigestive squamous cell carcinomas (ASCC) constitute a major source of global cancer deaths. Patients typically present with advanced, incurable disease, so new means of detecting early disease are a research priority. Metabolite quantitation is amenable to point-of-care analysis and can be performed in ASCC surrogates such as breath and saliva. The purpose of this systematic review is to summarise progress of ASCC metabolomic studies, with an emphasis on the critical appraisal of methodological quality and reporting. Method. A systematic online literature search was performed to identify studies reporting metabolic biomarkers of ASCC. This review was conducted in accordance with the recommendations of the Cochrane Library and MOOSE guidelines. Results. Thirty studies comprising 2117 patients were included in the review. All publications represented phase-I biomarker discovery studies, and none validated their findings in an independent cohort. There was heterogeneity in study design and methodological and reporting quality. Sensitivities and specificities were higher in oesophageal and head and neck squamous cell carcinomas compared to those in lung squamous cell carcinoma. The metabolic phenotypes of these cancers were similar, as was the kinetics of metabolite groups when comparing blood, tissue, and breath/saliva concentrations. Deregulation of amino acid metabolism was the most frequently reported theme. Conclusion. Metabolite analysis has shown promising diagnostic performance, especially for oesophageal and head and neck ASCC subtypes, which are phenotypically similar. However, shortcomings in study design have led to inconsistencies between studies. To support future studies and ultimately clinical adoption, these limitations are discussed.
- Open Access
- 11 December 2017
- Published by SynthesisHub Advance Scientific Research in European Journal of Molecular & Clinical Medicine
- Vol. 2, 30
Case report: A rare presentation of right illiac fossa pain
Introduction: Emphysematous pyelonephritis is a rare, life threatening acute suppuration of the kidney, characterised by the presence of air in the renal parenchyma, sometimes extending to the surrounding tissue. E. Coli and Klebsiella are the most common causative organisms, but the exact pathogenesis is poorly understood. It carries a high mortality, cited up to 50% and therefore requires prompt diagnosis and management. Case description: A 52-year old woman presented to A&E with a two day history of severe left-sided abdominal pain, rigors, vomiting and increased urinary frequency. Her past medical history was significant for non-insulin dependent Type 2 diabetes mellitus, a well-established risk factor that is present in 90% of cases. On examination, she had marked left flank tenderness, tachycardia and pyrexia. Bloods showed raised inflammatory markers with a severe AKI.
- 11 December 2017
- Published by SynthesisHub Advance Scientific Research in European Journal of Molecular & Clinical Medicine
- Vol. 2, 30
Open AccessCase report: A rare presentation of right illiac fossa pain
Introduction: Emphysematous pyelonephritis is a rare, life threatening acute suppuration of the kidney, characterised by the presence of air in the renal parenchyma, sometimes extending to the surrounding tissue. E. Coli and Klebsiella are the most common causative organisms, but the exact pathogenesis is poorly understood. It carries a high mortality, cited up to 50% and therefore requires prompt diagnosis and management. Case description: A 52-year old woman presented to A&E with a two day history of severe left-sided abdominal pain, rigors, vomiting and increased urinary frequency. Her past medical history was significant for non-insulin dependent Type 2 diabetes mellitus, a well-established risk factor that is present in 90% of cases. On examination, she had marked left flank tenderness, tachycardia and pyrexia. Bloods showed raised inflammatory markers with a severe AKI.
- 1 October 2015
- Published by Elsevier in The Surgeon
- Vol. 13 (5) , 267-270
Quality of life after total and subtotal gastrectomy for gastric carcinoma
- 1 October 2015
- Published by Elsevier in The Surgeon
- Vol. 13 (5) , 267-270
Quality of life after total and subtotal gastrectomy for gastric carcinoma